Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.65 USD | -0.95% | +0.97% | +3.51% |
20/05 | Entrada Therapeutics Insider Sold Shares Worth $287,695, According to a Recent SEC Filing | MT |
16/05 | Entrada Therapeutics Insider Bought Shares Worth $364,673, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.51% | 502M | |
+18.93% | 125B | |
+14.51% | 108B | |
-4.81% | 24.57B | |
+3.23% | 22.82B | |
-10.44% | 18.19B | |
-41.74% | 16.54B | |
-12.66% | 16.5B | |
+2.44% | 13.39B | |
+28.30% | 11.1B |
- Stock Market
- Equities
- TRDA Stock
- News Entrada Therapeutics, Inc.
- Goldman Sachs Adjusts Entrada Therapeutics' Price Target to $10 from $22, Keeps Neutral Rating